About Gary Pharmaceuticals Private Limited
Data last updated:
Gary Pharmaceuticals Private Limited is a private limited company based in Ludhiana, Punjab, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 February 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232PB2003PTC025769. Its GSTIN is 03AACCG1662K1ZT (Punjab).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors Ravibir Singh Garewal (Whole-Time Director) and Sandip Garewal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Vpo Heeran Off – NH – 95 Near Kohara Chandigarh Road, Ludhiana, Punjab, India – 141112.
As per the financials filed for FY 2024, the company reported a revenue of ₹10.9 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net loss of ₹60.71 Lakh (net margin -5.6%) and EBITDA of -₹5.72 Lakh (EBITDA margin -0.5%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 1% over five years.
The company has about 23 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Gary Pharmaceuticals P. As per MCA filings, the company has open charges of ₹2.05 Cr and satisfied charges of ₹55 Lakh on record. Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website garypharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressVpo Heeran Off – NH – 95 Near Kohara Chandigarh Road, Ludhiana, Punjab, India – 141112
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Gary Pharmaceuticals Private Limited
The main business activity of Gary Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Gary Pharmaceuticals Private Limited FY 2024 filings available
Gary Pharmaceuticals Private Limited reported revenue of ₹10.9 Cr (down 6% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Gary Pharmaceuticals Private Limited
Revenue fell 6% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 1%. EBITDA fell 106% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Gary Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹10.9 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹5.72 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹60.71 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Gary Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -5.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Gary Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Gary Pharmaceuticals Private Limited
Gary Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biotime Pharmaceuticals Private Limited | ₹10.93 Cr (FY 2025) | •••• | •••• | 716.0% | •••• | Ambernath, Maharashtra, India |
| Hibiscus Pharmaceuticals Private Limited | ₹10.93 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Chennai, Tamil Nadu, India |
| Nilrise Pharmaceuticals Private Limited | ₹10.92 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Ahmedabad, Gujarat, India |
| Biotech Healthcare Limited | ₹10.92 Cr (FY 2025) | •••• | •••• | 107.0% | •••• | New Delhi, Delhi, India |
| Hymax Healthcare Private Limited | ₹10.9 Cr (FY 2025) | •••• | •••• | 18.0% | •••• | Jaipur, Rajasthan, India |
| Gary Pharmaceuticals Private Limited this company | ₹10.9 Cr (FY 2024) | •••• | •••• | -6.0% | •••• | Ludhiana, Punjab, India |
| Silver Line Laboratories Private Limited | ₹10.89 Cr (FY 2024) | •••• | •••• | 17.0% | •••• | New Delhi, Delhi, India |
| Badrivas Biotech Private Limited | ₹10.88 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | New Delhi, Delhi, India |
| Supervalue Pharmacy Private Limited | ₹10.87 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Lucknow, Uttar Pradesh, India |
| Vrudhi Lifesciences Private Limited | ₹10.84 Cr (FY 2025) | •••• | •••• | 104.0% | •••• | Mumbai, Maharashtra, India |
| A.N.Pharmacia Laboratories Pvt Ltd. | ₹10.84 Cr (FY 2022) | •••• | •••• | 1.0% | •••• | Kolkata, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Gary Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Gary Pharmaceuticals Private Limited
Gary Pharmaceuticals Private Limited is audited by RAKSHIT KHOSLA & ASSOCIATES for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAKSHIT KHOSLA & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Gary Pharmaceuticals Private Limited
Gary Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravibir Singh Garewal | Whole-Time Director | 04 Feb 2003 | 23 Years 8 Months | Current |
| Sandip Garewal | Director | 04 Feb 2003 | 23 Years 8 Months | Current |
Ownership and Shareholding of Gary Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Gary Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Jun 2024 | Hdfc Bank Limited | ₹30 Lakh | Open |
| 27 Sep 2018 | Hdfc Bank Limited | ₹1.75 Cr | Open |
| 06 Apr 2004 | Bank of Baroda | ₹55 Lakh | Satisfied |
Total charge records: 3 View all charges
Legal Cases of Gary Pharmaceuticals Private Limited
Gary Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed. Status as checked on 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ludhiana, Punjab | Criminal miscellaneous application | Filed against the company by State | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Gary Pharmaceuticals Private Limited
Gary Pharmaceuticals Private Limited has 6 MSME Form 1 returns on record between 2019 and 2024, listing 273 overdue payments to 30 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 30)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Farma Fusion(Bhiwandi) | •••• | •••• | •••• |
| Elite Conversions(Ludhiana) | •••• | •••• | •••• |
| Sapphire Flexipack Private Limited | •••• | •••• | •••• |
| Premier Extrusions(Delhi) | •••• | •••• | •••• |
| B.P.Agro Chemicals(Kashipur) | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 6 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Gary Pharmaceuticals Private Limited
Gary Pharmaceuticals operates one associated brand: Gary Pharmaceuticals P. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures dermatology products like creams and tablets for skin issues. | garypharma.com |
Employees and EPFO Compliance at Gary Pharmaceuticals Private Limited
Gary Pharmaceuticals Private Limited has a workforce of 23 employees as of Mar 08, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Gary Pharmaceuticals Private Limited
Gary Pharmaceuticals Private Limited has 3 board changes on record since 2003: 2 appointments and 1 cessation. The latest: Ravibir Singh Garewal ceased to be Director on 01 Oct 2017.
Credit Ratings, Litigation & Regulatory Alerts for Gary Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Gary Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Gary Pharmaceuticals Private Limited
Gary Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AACCG1662K1ZT | Punjab | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Gary Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gary Pharmaceuticals Private Limited
Gary Pharmaceuticals is an active private limited company based in Ludhiana, Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 February 2003 (23+ years old) and is registered under CIN U24232PB2003PTC025769.
Gary Pharmaceuticals reported revenue of ₹10.9 Cr for FY 2024 (down 6% YoY).
Gary Pharmaceuticals has 2 current directors:
- Ravibir Singh Garewal - Whole-Time Director
- Sandip Garewal - Director
Gary Pharmaceuticals reported a net loss of ₹60.71 Lakh (net margin -5.6%) and EBITDA of -₹5.72 Lakh (EBITDA margin -0.5%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Gary Pharmaceuticals is 9% over three years and 1% over five years. In the latest year (FY 2024) revenue fell 6%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Gary Pharmaceuticals is 03AACCG1662K1ZT, registered in Punjab.
The CIN (Corporate Identification Number) of Gary Pharmaceuticals is U24232PB2003PTC025769. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gary Pharmaceuticals has 1 court case on record: 1 filed against it.
Gary Pharmaceuticals was incorporated on 04 February 2003, making it 23+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Gary Pharmaceuticals by revenue are Biotime Pharmaceuticals Private Limited, Hibiscus Pharmaceuticals Private Limited, Nilrise Pharmaceuticals Private Limited, Biotech Healthcare Limited, Hymax Healthcare Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Ravibir Singh Garewal ceased to be Director on 01 Oct 2017. Ravibir Singh Garewal was appointed as Whole-Time Director on 04 Feb 2003. Sandip Garewal was appointed as Director on 04 Feb 2003.
Gary Pharmaceuticals has 6 MSME Form 1 returns on record between 2019 and 2024, listing 273 overdue payments to 30 micro and small suppliers. The latest return was filed on 22 May 2024.